Irreversible And Severe Alopecia Following Docetaxel Or Paclitaxel Cytotoxic Therapy For Breast Cancer

    Christos Prevezas, B. Matard, L. Pinquier, P. Reygagne
    Image of study
    TLDR Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.
    The document discussed cases of irreversible and severe alopecia in patients who underwent cytotoxic therapy with docetaxel or paclitaxel for breast cancer. The study highlighted that these chemotherapeutic agents, commonly used in breast cancer treatment, could lead to significant and permanent hair loss, which is a distressing side effect for patients. The findings underscored the need for healthcare providers to inform patients about this potential outcome and consider it when planning treatment regimens.
    Discuss this study in the Community →

    Cited in this study

    2 / 2 results